Skip to main content
. 2023 Feb 16;11(2):590. doi: 10.3390/biomedicines11020590

Table 1.

Distribution of Sociodemographic Data.

Schizophrenia
(n = 52)
Control (n = 38) x2 (p)
n (%) n (%)
Gender Male 42 (80.8) 31 (81.6) 0.009 (0.573)
Female 10 (19.2) 7 (18.4)
Marital Status Married 11 (21.2) 19 (50) 8.221 (0.004)
Single 41 (78.8) 19 (50)
Educational Status Illiterate 29 (55.8) 7 (18.4) 12.856 (0.005)
Primary School 9 (17.3) 13 (34.2)
Secondary School 8 (15.4) 11 (28.9)
University 6 (11.5) 7 (18.4)
Smoking Present 38 (73.1) 26 (68.4) 0.232 (0.401)
None 14 (26.9) 12 (31.6)
Antipsychotic Drugs Used Olanzapine 11 (21.2) - - -
Olanzapine + risperidone 11 (21.2) - -
Olanzapine + haloperidol 10 (19.2) - -
Risperidone 10 (19.2) - -
Olanzapine + quetiapine 10 (19.2) - -
Mean ± SD Mean ± SD t (p)
Age 36.135 ± 9.826 34.737 ± 9.246 0.683 (0.496)
BMI (kg/m2) 26.211 ± 4.006 25.315 ± 3.595 1.093 (0.277)
Illness Duration (years) 7.712 ± 5.932 - -

Chi-Square Analysis; Independent Groups t-Test. BMI: body mass index.